Home › Funds › State Street › State Street SPDR S&P Health Care Equipment ETF
Fund family: State Street · Filed by SPDR SERIES TRUST (CIK 1064642) · SEC series S000012330
Ticker: XHE (C000033546)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 413 with, 261 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as State Street’s manager page (773,265 ballot items across 134 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | State Street | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 97.2% | 648 | 89.7% | 592,191 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 6.8% | 3,767 |
Each ballot item this fund voted is set against the votes of the other State Street funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most State Street funds on all 665 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 99.6% of this fund’s 674 such votes could be given a sector; the other 3 (0.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 655 | 248 | 37.9% |
| Technology | 16 | 12 | 75.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 466 | 171 |
| Say-on-Pay | 70 | 29 |
| Audit-related | 67 | 36 |
| Compensation | 34 | 16 |
| Corporate Governance | 21 | 8 |
| Capital Structure | 12 | 1 |
| Shareholder Rights and Defenses | 5 | 0 |
| Extraordinary Transactions | 4 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Senseonics Holdings, Inc. | September 29, 2025 | $6M | 1 | 0 |
| Glaukos Corporation | May 28, 2026 | $6M | 4 | 4 |
| Haemonetics Corporation | July 24, 2025 | $5M | 11 | 4 |
| AtriCure, Inc. | May 18, 2026 | $4M | 13 | 5 |
| Axogen, Inc. | June 23, 2026 | $4M | 10 | 1 |
| Edwards Lifesciences Corporation | May 7, 2026 | $3M | 12 | 4 |
| DexCom, Inc. | May 27, 2026 | $3M | 14 | 6 |
| SI-BONE, Inc. | June 4, 2026 | $3M | 4 | 3 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 28, 2026 | Glaukos Corporation | Election of Directors: Denice M. Torres | For | Against |
| May 28, 2026 | Glaukos Corporation | Election of Directors: Aimee S. Weisner | For | Against |
| July 24, 2025 | Haemonetics Corporation | Election of Directors: Charles J. Dockendorff | For | Against |
| July 24, 2025 | Haemonetics Corporation | Election of Directors: Mark W. Kroll | For | Against |
| May 18, 2026 | AtriCure, Inc. | Election of Directors: Deborah H. Telman | For | Against |
| May 18, 2026 | AtriCure, Inc. | Election of Directors: Robert S. White | For | Against |
| June 23, 2026 | Axogen, Inc. | To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. | For | Against |
| May 7, 2026 | Edwards Lifesciences Corporation | Election of Directors: Kieran T. Gallahue | For | Against |
| May 7, 2026 | Edwards Lifesciences Corporation | Election of Directors: Nicholas J. Valeriani | For | Against |
| May 27, 2026 | DexCom, Inc. | To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman | For | Against |
| May 27, 2026 | DexCom, Inc. | To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos | For | Against |
| June 4, 2026 | SI-BONE, Inc. | Election of Directors: Jeffrey W. Dunn | For | Against |
679 ballot items at 68 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, State Street SPDR S&P Health Care Equipment ETF (XHE) voted at 68 shareholder meetings of 65 companies, on 679 ballot items in all. Where management made a recommendation, the fund followed it on 61.3% of the items and voted against it 261 times. Its most frequent area of disagreement was director elections (171 of its votes against management). It voted on 4 shareholder proposals. It voted FOR the board's own proposals more often than State Street's funds as a whole (97.2% against 89.7%). It voted the same way as most State Street funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of State Street’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.